BIMI Holdings Inc.
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $11.8M | $21.3M | $12.8M | $157,978 | — | $8.5M |
| Operating income | −$15.3M | −$31.9M | −$3.8M | −$985,974 | −$212,582 | −$1.2M |
| Net income | −$22.4M | −$35.0M | −$2.0M | −$4.4M | −$16.8M | −$1.6M |
| Total assets | $35.7M | $38.1M | $33.2M | $30.1M | $23.1M | $41.4M |
| Total liabilities | $30.5M | $26.8M | $16.3M | $21.5M | $13.1M | $14.1M |
| Equity | $4.0M | $11.2M | $16.7M | $8.7M | $10.0M | $27.3M |
| EPS (diluted) | $-8.38 | $-65.12 | — | — | — | $-0.22 |
| Shares out. | 10.4M | 20.1M | 10.2M | 8.1M | 7.6M | 7.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −129.7%
- Net margin
- −189.3%
- Return on equity
- −553.2%
- Return on assets
- −62.7%
- Return on capital (ROCE)
- −148.2%
- Liabilities / assets
- 85.4%
- Debt / equity
- 7.53×
- Book value / share
- $0.39
- Revenue growth (YoY)
- −44.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -9.54distress
- Accruals / assets
- −34.0%clean
- Beneish M-Score
- -5.08normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 2, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2023
- NT 10-Qmissed a reporting deadline ↗May 16, 2023
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Oudom FnuActivist (13D)Jun 20, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Oudom FnuDirector | Jun 12, 2024 | Grant | 1.1M | $0.00 |
| Tiewei SongOfficer — CEO | Feb 26, 2024 | Sell | 724 | $4.01 |
| Tiewei SongOfficer — CEO | Feb 28, 2024 | Sell | 4,000 | $4.08 |
| Tiewei SongOfficer — CEO | Jul 19, 2022 | Grant | 100,000 | $49840.00 |
| Tiewei SongOfficer — CEO | Jul 18, 2022 | Grant | 124,427 | $58817.00 |
| Oudom FnuOfficer — Chaiman | Jul 19, 2022 | Grant | 12.5M | $0.40 |
| Gang LiOfficer — Chief Executive Officer | Apr 9, 2018 | Sell | 800,000 | $1.40 |
| Lihua WangOfficer — Chief Financial Officer | Apr 9, 2018 | Sell | 200,000 | $1.44 |
| Lihua WangOfficer — Chief Financial Officer | May 7, 2015 | J | 166,828 | $2.06 |
| Gang LiOfficer — Chief Executive Officer | May 7, 2015 | J | 667,314 | $2.06 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeJul 29, 2024
- Director / officer changeJun 4, 2024
- Entered a material agreementMay 24, 2024
- Delisting / listing-standard noticeMay 20, 2024
- Delisting / listing-standard noticeApr 23, 2024
- Other material eventMar 28, 2024
- Amended charter or bylawsJan 8, 2024
- Other material eventJan 5, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 25-NSEJan 24, 2025
- 8-KCURRENT REPORTJul 29, 2024
- SCHEDULE 13D/AJun 20, 2024
- SCHEDULE 13DJun 17, 2024
- 4PRIMARY DOCUMENTJun 13, 2024
- UPLOADJun 4, 2024
- 8-KFORM 8-KJun 4, 2024
- CORRESPMay 29, 2024
- 8-KCURRENT REPORTMay 24, 2024
- 8-KCURRENT REPORTMay 20, 2024
- UPLOADMay 17, 2024
- CORRESPMay 8, 2024
- 8-KCURRENT REPORTApr 23, 2024
- UPLOADApr 23, 2024
- NT 10-KNOTIFICATION OF LATE FILINGApr 2, 2024
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.